investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Sphingosine-1-Phosphate in Breast Cancer Progression and Lymphangiogenesis
Kazuaki Takabe
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Kazuaki Takabe
Virginia Commonwealth University
Richmond, United States
Related projects
Alison Motsinger-Reif
Genetic Etiology of Cancer Drug Response
Breast
Sergey Korolev
Structural and Functional Studies of Tumor Suppressor Proteins PALB2 and BRCA2
Breast
Rong Li
Regulation of Hormone Production by Matrix Proteins
Breast
Joshua Labaer
Biomarker Detection Using NAPPA Tumor Antigen Arrays
Breast
Andrea Hope Bild
Integrative signaling models to decipher complex cancer phenotypes
Breast
Thomas Sayers
Mechanisms of Immune-mediated Tumor Cell Destruction
Breast
Nicholas K Tonks
Protein Tyrosine Dephosphorylation & Signal Transduction
Breast
David E Goldgar
A Comprehensive Approach to Breast Cancer Susceptibility Across the Risk Spectrum
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast